Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2017 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | N/A | 14,420 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 2,450 |
| Other Working Capital | N/A | N/A | N/A | N/A | 1,760 |
| Other Operating Activity | 0 | 0 | 0 | 0 | 8,140 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $26,770 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -29,440 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-29,440 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 60 |
| Beginning Cash Position | N/A | N/A | N/A | N/A | 3,940 |
| End Cash Position | N/A | N/A | N/A | N/A | 1,330 |
| Net Cash Flow | $N/A | $N/A | $N/A | $N/A | $-2,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | 26,770 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 26,770 |